DK0443224T3 - Anvendelse af thrombospondin til fremskyndelse af sårheling - Google Patents

Anvendelse af thrombospondin til fremskyndelse af sårheling

Info

Publication number
DK0443224T3
DK0443224T3 DK90250335.8T DK90250335T DK0443224T3 DK 0443224 T3 DK0443224 T3 DK 0443224T3 DK 90250335 T DK90250335 T DK 90250335T DK 0443224 T3 DK0443224 T3 DK 0443224T3
Authority
DK
Denmark
Prior art keywords
thrombospondin
wound healing
accelerate wound
pharmaceutical compositions
accelerate
Prior art date
Application number
DK90250335.8T
Other languages
Danish (da)
English (en)
Inventor
Jacob Eyal
George Paul Tuszynski
Original Assignee
Grace W R & Co
Pennsylvania Med College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grace W R & Co, Pennsylvania Med College filed Critical Grace W R & Co
Application granted granted Critical
Publication of DK0443224T3 publication Critical patent/DK0443224T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK90250335.8T 1990-02-22 1990-12-21 Anvendelse af thrombospondin til fremskyndelse af sårheling DK0443224T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/483,500 US5155038A (en) 1990-02-22 1990-02-22 Use of thrombospondin to promote wound healing

Publications (1)

Publication Number Publication Date
DK0443224T3 true DK0443224T3 (da) 1994-05-02

Family

ID=23920296

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90250335.8T DK0443224T3 (da) 1990-02-22 1990-12-21 Anvendelse af thrombospondin til fremskyndelse af sårheling

Country Status (8)

Country Link
US (1) US5155038A (de)
EP (1) EP0443224B1 (de)
JP (1) JPH04211019A (de)
AT (1) ATE103815T1 (de)
CA (1) CA2031817C (de)
DE (1) DE69007964T2 (de)
DK (1) DK0443224T3 (de)
ES (1) ES2063250T3 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192744A (en) * 1990-01-12 1993-03-09 Northwestern University Method of inhibiting angiogenesis of tumors
US5468505A (en) * 1992-02-28 1995-11-21 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
US5399667A (en) 1993-03-05 1995-03-21 Washington University Thrombospondin receptor binding peptides
US5627265A (en) * 1993-03-05 1997-05-06 Washington University Receptor for cell-binding domain of thrombospondins
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US5877149A (en) 1995-06-07 1999-03-02 Beaulieu; Andre Deepithelialized skin diffusion cell system
US5641483A (en) * 1995-06-07 1997-06-24 Beaulieu; Andre Wound healing formulations containing human plasma fibronectin
US7112320B1 (en) 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
CN1069213C (zh) * 1995-12-08 2001-08-08 上海贝特生物技术有限公司 造血前体细胞保护剂
US6461640B1 (en) 1995-12-08 2002-10-08 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6716963B1 (en) * 1998-05-22 2004-04-06 Abbott Laboratories Peptide antiangiogenic drugs
AU2763099A (en) 1998-06-22 2000-01-10 Charles E. Worden Enriched platelet wound healant
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6380161B1 (en) 1999-06-21 2002-04-30 Inkine Pharmaceutical Company, Inc. Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions
AU2001274923A1 (en) * 2000-05-23 2001-12-03 Lexicon Genetics Incorporated Novel human thrombospondin-like proteins and polynucleotides encoding the same
EP4606428A3 (de) * 2018-06-27 2025-11-05 Juvena Therapeutics, Inc. Heparin-assoziierte polypeptide und deren verwendungen
EP4081241A4 (de) 2019-12-24 2024-05-01 Juvena Therapeutics, Inc. Regenerative polypeptide und verwendungen dafür
EP4359425B1 (de) 2021-06-21 2026-08-05 Juvena Therapeutics, Inc. Igf2-fusionspolypeptid und verwendung bei der behandlung von muskeldystrophie, sarkopenie, kachexie oder muskelverletzungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614517A (en) * 1982-08-04 1986-09-30 La Jolla Cancer Research Foundation Tetrapeptide
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide

Also Published As

Publication number Publication date
EP0443224B1 (de) 1994-04-06
DE69007964T2 (de) 1994-09-22
DE69007964D1 (de) 1994-05-11
US5155038A (en) 1992-10-13
CA2031817A1 (en) 1991-08-23
JPH04211019A (ja) 1992-08-03
CA2031817C (en) 2002-02-12
ATE103815T1 (de) 1994-04-15
EP0443224A1 (de) 1991-08-28
ES2063250T3 (es) 1995-01-01

Similar Documents

Publication Publication Date Title
DE69007964D1 (de) Verwendung von Thrombospondin zur Beschleunigung der Wundheilung.
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
BR9403783A (pt) Uso de uma composição cosmética
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
NL300136I2 (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
EP0202298A4 (de) Heilmittel für wunden.
FI905196A7 (fi) Formulointeja pitkäaikaisia vapautussidoksia varten ja niiden käyttö
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
SE7903186L (sv) Cerebralverksamt medel
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
ATE290397T1 (de) Formulierung fur die wundheilung mit menschlichem plasma fibronektin
FI915783A7 (fi) N-jodipropargyylioksikarbonyyliaminohappoesterit ja niiden johdannaiset sekä niiden käyttö antimikrobisina aineina
ES2101230T3 (es) Nuevos derivados de sustancias anti-inflamatorias, analgesicas y/o antipireticas no estereoideas, su uso y formulaciones farmaceuticas que las contienen.
ES2068935T3 (es) Piridazinonas con actividad insecticida y acaricida y composiciones que las contienen.
DE68913739D1 (de) Kosmetische und hautbehandlungs-zusammensetzungen.
IT1240683B (it) Composizione farmaceutica contenente egf
FI934325A7 (fi) Hyönteismyrkkykoostumus ja hyönteismyrkky-yksiköitä
ATE126435T1 (de) Antiherpes-castanosperminester.
ATE158947T1 (de) Hautregenerierende kosmetische zusammensetzung
IT8021550A0 (it) Derivati adenosinici ad attivita'antinfiammatoria ed analgesica e composizioni terapeutiche che licontengono come principio attivo.
DE69104961D1 (de) Anwendung von Thiazolylalkoxyacrylaten in der Herstellung von Insektiziden und/oder Akanizide-Zusammensetzungen.
ITTO930024A0 (it) Composizione per accelerare la rimarginazione di ferite
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
DE69230644D1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen